We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Radiation Reduction Standards Proposed for Worldwide Implementation

By HospiMedica International staff writers
Posted on 15 Nov 2012
A Canadian heart institute is putting into play what could become a transformation in medical imaging in Canada as it presented findings in radiation reduction for the diagnosis of cardiovascular disease. More...


As a result of an initiative that combines optimizing test protocols, state-of-the art equipment, and high-tech software, two-thirds of the Ottawa Heart Institutes (UOHI; Ottawa, Ontario, Canada) nuclear cardiology patients are currently receiving half the radiation dosage that they would normally get. Radiation reduction techniques have been accomplished across all kinds of radiation-based cardiac imaging--computed tomography (CT), nuclear imaging, and positron emission tomography (PET). The Heart Institute is one of only a one of a couple of centers in Canada with the in-house expertise to assess and clinically apply these latest developments across these technologies.

The American Society for Nuclear Cardiology has challenged the nuclear cardiology community to reduce radiation exposure below 9 millisieverts (mSv) by 2014. The techniques being employed at the Heart Institute regularly reduce exposure to 5 mSv, and frequently much less, putting UOHI well ahead of the game. This figure has not bottomed out, as efforts will continue to minimize radiation wherever possible.

“Our clinicians are taking a much more critical look at who they are testing with radioactive methods and making decisions based upon risk and necessity which will only expose patients to radiation who truly need the test,” said Dr. Benjamin Chow, codirector of cardiac radiology at the University of Ottawa Heart Institute. These responsible practices, along with a judicious use of technology, could revolutionize cardiac imaging in Canada.”

The payback for this effort include reduced radiation dosages for patients, greater flexibility for customizing modalities for patients, and, in some instances, a decreased need placed on radioisotopes. For example, for younger patients, radiation exposure presents greater risks because they have more years in which cancer could develop. So lessening their dosage is a high priority. In the case of older patients whose lives may be threatened by an immediate cardiac problem condition, the advantages would overshadow the small risk of developing cancer later in life.

UOHI also uses a combination of effective applications that facilitate a better diagnosis of cardiovascular problems. The cadmium-zinc-telluride camera system used for nuclear imaging is a significant development and it was implemented by Dr. Glenn Wells, medical physicist in nuclear cardiology. The Heart Institute was one of the first centers in the world with this technology in 2009, and it had a major impact on reducing radiation in perfusion single emission computed tomography (SPECT) scans, the most typical cardiac imaging modality.

The introduction of PET imaging in the late 1990s, which provides much more detailed imagery with much lower levels of injected isotopes, has also had an impact on reducing radiation exposure. The use of these cameras in Canada is still uncommon but increasing.

Software is another critical part of imaging, transforming the scanner data into coherent two- or even three-dimensional (3D) images of what is seen in a patient’s body. The Heart Institute has helped commercial developers evaluate and enhance new, sophisticated software packages for both PET and SPECT scanners that maintain image quality while using less radioactive isotopes.

Radiation has become a concern for both medical professionals and patients; however, frequently people do not realize the considerable advantages of very effective diagnostic imaging modalities that may require very low amounts of medical radiation. “Careful and appropriate selection of the right test for the right patient balancing benefit and risk enables optimal patient care,” said Dr. Terrence Ruddy, director of nuclear cardiology, University of Ottawa Heart Institute.

Related Links:
Ottawa Heart Institutes



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.